<?xml version="1.0" encoding="UTF-8"?>
<Label drug="zarontin" track="TAC2017_ADR">
  <Text>
    <Section name="adverse reactions" id="S1">    ADVERSE REACTIONS

    Body As A Whole:  Allergic reaction. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).



   Gastrointestinal System:  Gastrointestinal symptoms occur frequently and include anorexia, vague gastric upset, nausea and vomiting, cramps, epigastric and abdominal pain, weight loss, and diarrhea. There have been reports of gum hypertrophy and swelling of the tongue.



   Hemopoietic System:  Hemopoietic complications associated with the administration of ethosuximide have included leukopenia, agranulocytosis, pancytopenia, with or without bone marrow suppression, and eosinophilia.



   Nervous System:  Neurologic and sensory reactions reported during therapy with ethosuximide have included drowsiness, headache, dizziness, euphoria, hiccups, irritability, hyperactivity, lethargy, fatigue, and ataxia. Psychiatric or psychological aberrations associated with ethosuximide administration have included disturbances of sleep, night terrors, inability to concentrate, and aggressiveness. These effects may be noted particularly in patients who have previously exhibited psychological abnormalities. There have been rare reports of paranoid psychosis, increased libido, and increased state of depression with overt suicidal intentions.



   Integumentary System:  Dermatologic manifestations which have occurred with the administration of ethosuximide have included urticaria, pruritic erythematous rashes, and hirsutism.



   Special Senses:  Myopia  .  



   Genitourinary System:  Vaginal bleeding, microscopic hematuria.
</Section>
  </Text>
  <Mentions />
  <Relations />
  <Reactions />
</Label>
